Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Indivior Income After Taxes 2012-2024 | INDV

Indivior income after taxes from 2012 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
  
Indivior Annual Income After Taxes
(Millions of US $)
2023 $2
2022 $-53
2021 $205
2020 $-148
2019 $134
2018 $275
2017 $58
2016 $35
2015 $228
2014 $403
2013 $489
2012 $607
2011 $614
Indivior Quarterly Income After Taxes
(Millions of US $)
2024-09-30 $4
2024-06-30 $-107
2024-03-31 $47
2023-12-31 $54
2023-09-30 $-135
2023-06-30 $39
2023-03-31 $44
2022-12-31 $-183
2022-09-30 $41
2022-06-30 $48
2022-03-31 $41
2021-12-31 $36
2021-09-30 $27
2021-06-30 $62
2021-03-31 $80
2020-12-31 $-16
2020-09-30 $10
2020-06-30 $21
2020-03-31 $-163
2019-12-31 $-55
2019-09-30 $48
2019-06-30 $75
2019-03-31 $66
2018-12-31 $23
2018-09-30 $89
2018-06-30 $70
2018-03-31 $93
2017-12-31 $-145
2017-09-30 $50
2017-06-30 $73
2017-03-31 $80
2016-12-31 $77
2016-09-30 $-149
2016-06-30 $57
2016-03-31 $50
2015-12-31 $37
2015-09-30 $48
2015-06-30 $66
2015-03-31 $77
2014-12-31
2014-09-30 $93
2014-06-30 $114
2013-12-31
2012-12-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.504B $1.093B
Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, cocaine intoxication and co-occurring conditions, such as schizophrenia. The Company markets and promotes SUBOXONE (buprenorphine and naloxone) Sublingual Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablet, and SUBUTEX (buprenorphine) Sublingual Tablet, each buprenorphine-based treatment for opioid. Indivior PLC is based in United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.873B 31.52
Zoetis (ZTS) United States $70.142B 26.46
Daiichi Sankyo, - (DSNKY) $43.872B 26.73
Takeda Pharmaceutical (TAK) Japan $43.719B 9.68
Sandoz Group AG (SDZNY) Switzerland $20.592B 0.00
Merck (MKKGY) Germany $18.255B 16.35
Astellas Pharma (ALPMY) Japan $17.355B 12.30
United Therapeutics (UTHR) United States $17.000B 16.72
Summit Therapeutics (SMMT) United States $15.929B 0.00
Shionogi (SGIOY) Japan $12.267B 12.29
Neurocrine Biosciences (NBIX) United States $11.392B 34.73
Corcept Therapeutics (CORT) United States $7.704B 58.36
Madrigal Pharmaceuticals (MDGL) United States $7.495B 0.00
Orion OYJ (ORINY) Finland $7.424B 20.87
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.245B 0.00
Stevanato Group S.p.A (STVN) Italy $6.166B 39.92
Grifols, S.A (GRFS) Spain $5.074B 0.00
Ionis Pharmaceuticals (IONS) United States $5.023B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.650B 9.52
Recursion Pharmaceuticals (RXRX) United States $4.247B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.394B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.687B 12.18
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.432B 14.54
Hypermarcas (HYPMY) Brazil $2.185B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.098B 0.00
Soleno Therapeutics (SLNO) United States $2.047B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.945B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.766B 0.00
Evotec AG (EVO) Germany $1.566B 0.00
Ardelyx (ARDX) United States $1.506B 0.00
Dyne Therapeutics (DYN) United States $1.406B 0.00
Guardian Pharmacy Services (GRDN) United States $1.323B 0.00
ARS Pharmaceuticals (SPRY) United States $1.166B 0.00
Ocular Therapeutix (OCUL) United States $1.160B 0.00
Xencor (XNCR) United States $1.134B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.127B 0.00
Harrow (HROW) United States $1.078B 0.00
Enliven Therapeutics (ELVN) United States $1.070B 0.00
Collegium Pharmaceutical (COLL) United States $0.965B 5.27
Bioventus (BVS) United States $0.838B 26.46
Avadel Pharmaceuticals (AVDL) Ireland $0.810B 0.00
Cronos Group (CRON) Canada $0.750B 0.00
Relay Therapeutics (RLAY) United States $0.696B 0.00
Verve Therapeutics (VERV) United States $0.683B 0.00
USANA Health Sciences (USNA) United States $0.595B 11.02
Xeris Biopharma Holdings (XERS) United States $0.592B 0.00
KalVista Pharmaceuticals (KALV) United States $0.529B 0.00
OmniAb (OABI) United States $0.518B 0.00
Elite Pharmaceuticals (ELTP) United States $0.509B 0.00
Altimmune (ALT) United States $0.482B 0.00
Savara (SVRA) United States $0.481B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.479B 0.00
ProKidney (PROK) United States $0.458B 0.00
Organogenesis (ORGO) United States $0.444B 0.00
Akebia Therapeutics (AKBA) United States $0.432B 0.00
Siga Technologies (SIGA) United States $0.431B 5.03
Zevra Therapeutics (ZVRA) United States $0.413B 0.00
Aldeyra Therapeutics (ALDX) United States $0.404B 0.00
Oruka Therapeutics (ORKA) United States $0.377B 0.00
Esperion Therapeutics (ESPR) United States $0.374B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.363B 147.29
Tourmaline Bio (TRML) United States $0.323B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.310B 0.00
CytoDyn (CYDY) United States $0.292B 0.00
Korro Bio (KRRO) United States $0.276B 0.00
Aquestive Therapeutics (AQST) United States $0.276B 0.00
Avita Medical (RCEL) United States $0.268B 0.00
Nature's Sunshine Products (NATR) United States $0.264B 15.71
Heron Therapeutics (HRTX) United States $0.257B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.241B 0.00
4D Molecular Therapeutics (FDMT) United States $0.219B 0.00
Inhibikase Therapeutics (IKT) United States $0.214B 0.00
Profound Medical (PROF) Canada $0.213B 0.00
Larimar Therapeutics (LRMR) United States $0.211B 0.00
MediWound (MDWD) Israel $0.199B 0.00
Nektar Therapeutics (NKTR) United States $0.184B 0.00
Lyell Immunopharma (LYEL) United States $0.181B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.177B 0.00
Nanobiotix S.A (NBTX) France $0.170B 0.00
Acrivon Therapeutics (ACRV) United States $0.165B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
VAXART, INC (VXRT) United States $0.165B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.150B 0.00
Silence Therapeutics (SLN) United Kingdom $0.150B 0.00
Champions Oncology (CSBR) United States $0.149B 0.00
Lexeo Therapeutics (LXEO) United States $0.147B 0.00
Cassava Sciences (SAVA) United States $0.134B 0.00
Inotiv (NOTV) United States $0.132B 0.00
ElectroCore (ECOR) United States $0.129B 0.00
Telomir Pharmaceuticals (TELO) United States $0.125B 0.00
Achieve Life Sciences (ACHV) Canada $0.110B 0.00
Journey Medical (DERM) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.101B 0.00
Metagenomi (MGX) United States $0.096B 0.00
Galectin Therapeutics (GALT) United States $0.095B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Regulus Therapeutics (RGLS) United States $0.085B 0.00
Protara Therapeutics (TARA) United States $0.082B 0.00
Pyxis Oncology (PYXS) United States $0.080B 0.00
Nutriband (NTRB) United States $0.080B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.08
Karyopharm Therapeutics (KPTI) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Mural Oncology (MURA) Ireland $0.073B 0.00
Avalo Therapeutics (AVTX) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Fractyl Health (GUTS) United States $0.070B 0.00
Century Therapeutics (IPSC) United States $0.064B 0.00
Gain Therapeutics (GANX) United States $0.064B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Unicycive Therapeutics (UNCY) United States $0.062B 0.00
AleAnna (ANNA) United States $0.062B 0.00
OptiNose (OPTN) United States $0.060B 0.00
FibroGen (FGEN) United States $0.057B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.056B 0.00
AlloVir (ALVR) United States $0.052B 0.00
Iterum Therapeutics (ITRM) Ireland $0.051B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
SCYNEXIS (SCYX) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
NRx Pharmaceuticals (NRXP) United States $0.040B 0.00
Surrozen (SRZN) United States $0.039B 0.00
CASI Pharmaceuticals (CASI) China $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.034B 0.00
BioVie (BIVI) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Mannatech (MTEX) United States $0.021B 0.00
GlycoMimetics (GLYC) United States $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.020B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Biomerica (BMRA) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
Mangoceuticals (MGRX) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Relmada Therapeutics (RLMD) United States $0.010B 0.00
Ainos (AIMD) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.08
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Conduit Pharmaceuticals (CDT) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00